Danielle Weaver

Danielle Weaver is a Researcher at the University of Manchester within the Division of Immunology, Immunity to Infection and Respiratory Medicine. Her work focuses on mycobiome analysis, fungal infections, and transcriptomics, contributing to UN Sustainable Development Goals related to global health challenges. She has co-developed novel diagnostics for fungal infections and investigated the role of RNA interference in fungal pathogenesis.

Education & Research: Dr. Weaver holds a PhD in Microbiology from the University of Manchester (2018), focusing on N-linked glycosylation in Campylobacter species. Her research integrates next-generation sequencing (NGS), metagenomics, and transcriptomics to study microbial communities in respiratory diseases and infectious pathogens.

Research Themes:

• Mycobiome dynamics in critically ill patients (e.g., post-COVID-19)
• Functional genomics of Aspergillus fumigatus RNAi pathways
• Bacterial glycosylation as a target for diagnostic tools

Collaborations & Impact: Her work bridges fundamental research and clinical applications, with studies published in BMC Microbiology, RNA, and Frontiers in Microbiology. She collaborates internationally on fungal diagnostics and respiratory infection mechanisms.